AVENAT
LIVE

Serial Number

98656792

Owner

Ceapro Inc.

Attorney

Karl M. Zielaznicki, Esq.

Filing Date

Jul 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AVENAT Trademark

Serial Number: 98656792

AVENAT is a trademark filed by Ceapro Inc. on July 19, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). The application is currently pending registration.

Owner Contact Info

Ceapro Inc.

7824 - 51 Avenue NW

Entity Type: 03

Trademark Details

Filing Date

July 19, 2024

Registration Date

Not Registered

Goods & Services

(Based on 44(e))(Based on Intent To Use) Dietary and nutritional supplements for improving nail strength, supporting healthy skin and maintaining shiny hair; dietary and nutritional supplements for general health and wellbeing; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing avenanthramides for the treatment and prevention of inflammation, inflammatory bowel syndrome, joint inflammation, atherosclerosis, and cancer; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing oat beta glucan for modulating glucose metabolism, for preventing and treating metabolic diseases and disorders, and for lowering cholesterol; veterinary medicine products, namely, natural (non-antibiotic) anti-microbial preparations for the treatment of mastitis in animals; natural saponin-based preparations acting on the immune systems of animals and humans to help fight infection and disease; pharmaceutical medicine products for human and animal use, namely pharmaceutical preparations in the area of immunology and bioengineering for the treatment of immune-based diseases and disorders of the immune system, oat based preparations for use in the diagnosis and monitoring of diabetes, pharmaceutical preparations in cream, lotion and liquid gel forms for the moisturizing treatment of lips and skin and the anti-bacterial treatment of cold sores, herpes sores, acne and skin diseases, pharmaceutical anti-irritant and moisturizing cream, immune system stimulants; pharmaceutical preparations for skin care, namely medicated sunscreens, medicated skin creams, gels, balms and lotions, medicated shampoo, medicated lip balm; health care products, namely anti-irritant and moisturizing cream, shampoo; nutritional additives for animal feed, nutritional supplements, namely oat based supplements; additives to animal fodder in the nature of dietary supplements for medical purposes; pharmaceuticals preparation for immunology and inflammation based diseases; avenanthramides and oat beta glucan for use as ingredients in nutritional supplements; medicinal oils, other than essential oils (Based on Intent To Use) medicated skin care preparations, namely, creams, lotions, and gels; medicated skin care preparations, namely, creams, lotions and gels containing oat beta glucan; bandages for skin wounds; medicated bandages for dressings; bandages impregnated with oat beta glucan for medicinal purposes

Active chemical ingredients in the nature of avenanthramides and oat beta glucan for use in the manufacture of cosmeceuticals, nutraceuticals, and pharmaceuticals

Bread; flour and preparations made from cereals, namely, cereal bars, cereal-based snacks, and breakfast cereals; oat based food products, namely, oat bran, oat flour, oat starch, oat beta glucan, and noodles

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 4, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 4, 2026 CRFA
ASSIGNED TO LIE
Jun 3, 2026 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 2, 2026 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 30, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 30, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
May 30, 2026 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 30, 2026 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 2, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 2, 2025 GNSL
SUSPENSION LETTER WRITTEN
Sep 2, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 9, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 9, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 9, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 9, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 9, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 9, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 29, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2025 NWOS
NEW APPLICATION ENTERED
Jul 19, 2024 NWAP